Phase I/II Study to Evaluate the Safety and Efficacy of the Permanently Implantable LDR CivaSheet® in Combination With External Beam Radiation in the Treatment of Pancreatic Cancer
Summary
10/14/2020 Note: This trial is currently enrolling into the Phase II cohort.
The purpose of this phase I/II study is to determine the safety and efficacy of CivaSheet, a brachytherapy device that provides unidirectional radiation which utilizes active components (Palladium-103) of standard devices in a novel configuration, in the setting of suspected close or positive margins at the time of surgical tumor removal.
General Information
NCT#: NCT02843945
Study ID: CT004
Trial Phase: Phase I/II
Trial Sponsor: CivaTech Oncology
Therapies Used in This Trial: CivaSheet™
Sign In